US NRC proposes regulatory reforms to streamline medical byproduct licensing

The NRC is proposing amendments to reduce prescriptive barriers for medical use of byproduct materials, aiming to increase flexibility and modernize safety standards. This initiative follows Executive Order 14300, which mandates a comprehensive review of agency regulations to improve licensing efficiency for emerging medical technologies.